Literature DB >> 25116973

Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part I.

Brooke Walls, Laura Jordan, Lisa Diaz, Richard Miller.   

Abstract

The field of cutaneous oncology is exploding with innovative treatment options, specifically in the field of targeted therapy. These advances offer new hope to select patients with high risk skin cancers. Here we provide a two part series reviewing targeted therapy for non-melanoma skin cancer. We begin our discussion with basal cell carcinoma, moving beyond the first-in-class hedgehog inhibitors and highlighting promising clinical trials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25116973

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

Review 1.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

2.  I-BET726 suppresses human skin squamous cell carcinoma cell growth in vitro and in vivo.

Authors:  Zhengjun Liu; Ping Li; Yong-Qiang Yang; Shang Cai; Xiangwei Lin; Min-Bin Chen; Hailei Guo
Journal:  Cell Death Dis       Date:  2020-05-05       Impact factor: 8.469

3.  The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth.

Authors:  Yulong Wang; Li Ou; Xirong Li; Tingyu Zheng; Wei-Pei Zhu; Ping Li; Lijun Wu; Tianlan Zhao
Journal:  Cell Death Discov       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.